Category: Our News

CQDM and Oncopole are proud to announce the funding of a theranostic project, a pioneering approach set to transform cancer diagnosis and treatment

Announcement Montreal, May 13, 2025 – CQDM and l’Oncopole, pôle cancer du FRQ-santé, are proud to announce the funding of a collaborative research project as part of the Call for collaborative research projects on precision care in oncology. This project aims to evaluate the effectiveness of a radiopharmaceutical anti-cancer therapy, that can both diagnose cancer…

Effervescence Panel with Conscience

As part of our partnership with Conscience, CQDM is proud to co-host a panel at EFFERVESCENCE 2025, the must-attend life sciences event in North America.🎤 Panel: Building the Future Together – Open Science in Drug DevelopmentThis discussion will bring together Matt Goddeeris (Every Cure), Sébastien Giguère (Valence Discovery), Jason Karamchandani (C-BIG Repository, McGill University), and…

New hire, Kristin Davis, Project manager

Welcome to Kristin Davis, MSc, our new Project Manager, Scientific Affairs at CQDM! Kristin joined us in, bringing over five years of experience in research funding, both in grant administration and from the recipient’s perspective. She has successfully managed complex, interdisciplinary projects in public health, molecular biology, and psychiatry. With a BSc in Biochemistry from…

Congratulations to AmacaThera on its upcoming collaboration with a leading global pharmaceutical company!

This partnership was made possible through a CQDM Connect-Pharma call for proposals, an initiative that gives Canadian companies and researchers the opportunity to directly engage with CQDM’s international pharmaceutical members.CQDM plays a unique role as a facilitator of healthcare innovation, going well beyond financial investment. Thanks to its strong connections with major pharmaceutical players and…

Congratulations to Synucure Therapeutics on securing $2.8M in funding!

Congratulations to Synucure Therapeutics, which has just completed a $2.8 million financing round, with 50% of the funding coming from the Government of Québec through Investissement Québec as part of the Impulsion PME program.👏CQDM is proud to have supported this project by acting as an advisor and referring entity, helping facilitate access to this crucial…

Appointment of Véronique Dugas as President and Chief Executive Officer of CQDM

Announcement Montreal, March 12, 2025 – The CQDM Board of Directors is proud to announce the appointment of Véronique Dugas as the next President and Chief Executive Officer (CEO) of CQDM. She will succeed Diane Gosselin, who, after 17 years of dedicated service to the organization, including 13 years at its helm, will be retiring.…

Launch of Merck Digital Sciences Studio (MDSS) in Montréal

🚀💊 Are you ready to revolutionize the digital health and artificial intelligence (AI) sectors? Join the Merck Digital Sciences Studio (MDSS) and collaborate with a global leader! 🧬🔍 The MDSS program in partnership with Centech Mtl and CQDM is a six-month program in Montreal that equips startups in the digital health and AI sectors with…

CQDM, IVADO, and three Quebec-based companies invest $2M to accelerate the development of highly targeted, less toxic cancer therapies using AI       

Montreal, February 21, 2025 – CQDM is pleased to announce the funding of a collaborative research project aimed at developing new tumor-specific therapeutic candidates designed to minimize toxicities and side effects of oncology therapies, using an innovative approach based on artificial intelligence (AI).  This project, worth a total of $2,056,964, is being carried out jointly…